P. Shallie, Olugbenga Olayinka, H. Akpan, O. Otulana, O. Alese, B. Babatunde, Damilola Talabi, O. Shallie
{"title":"亚麻籽油对鱼藤酮帕金森病小鼠纹状体的潜在神经治疗作用","authors":"P. Shallie, Olugbenga Olayinka, H. Akpan, O. Otulana, O. Alese, B. Babatunde, Damilola Talabi, O. Shallie","doi":"10.9734/bjmmr/2017/34207","DOIUrl":null,"url":null,"abstract":"Aim: This study investigated the potential neuro-therapeutic effect of Flaxseed oil on the striatum of Rotenone mice model of Parkinson’ diseases’ Study Design: Fifty-six adult male and female mice ( Mus musculus) weighing between 23.9-26.3 grams were used for this study. The mice were randomly placed into four groups of fourteen mice each made up of equal number of male and female: A (Control; mice pellets), B (Rotenone 3 mg/kg, IP), C (Rotenone + Flaxseed oil 0.3 ml orally), and D (0.3 ml Flaxseed + Rotenone). Methodology: The brain were excised, weighed and appropriate sections taken and processed histology and stained with H&E and Nissl stains and immuno-cytochemically with GFAP. Results: The results showed significant (P<0.05) reduction in the neuronal cell count, body and relative brain to body weight, which were increased by flaxseed oil treatments. Rotenone induced neural and striatal bundle degeneration which were ameliorated by flaxseed oil treatment. Conclusion: In conclusion, the reduction in weight and neuronal derangements associated with rotenone induced Parkinson’s disease in this study were reduced or alleviated as a consequence of the treatment with flaxseed oil, and hence flaxseed oil could be considered as a potential therapeutic candidate in the management of Parkinson's disease.","PeriodicalId":9249,"journal":{"name":"British journal of medicine and medical research","volume":"24 1","pages":"1-9"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Potential Neuro-therapeutic Effect of Flaxseed Oil on the Striatum of Rotenone Mice Model of Parkinson’ Diseases\",\"authors\":\"P. Shallie, Olugbenga Olayinka, H. Akpan, O. Otulana, O. Alese, B. Babatunde, Damilola Talabi, O. Shallie\",\"doi\":\"10.9734/bjmmr/2017/34207\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim: This study investigated the potential neuro-therapeutic effect of Flaxseed oil on the striatum of Rotenone mice model of Parkinson’ diseases’ Study Design: Fifty-six adult male and female mice ( Mus musculus) weighing between 23.9-26.3 grams were used for this study. The mice were randomly placed into four groups of fourteen mice each made up of equal number of male and female: A (Control; mice pellets), B (Rotenone 3 mg/kg, IP), C (Rotenone + Flaxseed oil 0.3 ml orally), and D (0.3 ml Flaxseed + Rotenone). Methodology: The brain were excised, weighed and appropriate sections taken and processed histology and stained with H&E and Nissl stains and immuno-cytochemically with GFAP. Results: The results showed significant (P<0.05) reduction in the neuronal cell count, body and relative brain to body weight, which were increased by flaxseed oil treatments. Rotenone induced neural and striatal bundle degeneration which were ameliorated by flaxseed oil treatment. Conclusion: In conclusion, the reduction in weight and neuronal derangements associated with rotenone induced Parkinson’s disease in this study were reduced or alleviated as a consequence of the treatment with flaxseed oil, and hence flaxseed oil could be considered as a potential therapeutic candidate in the management of Parkinson's disease.\",\"PeriodicalId\":9249,\"journal\":{\"name\":\"British journal of medicine and medical research\",\"volume\":\"24 1\",\"pages\":\"1-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British journal of medicine and medical research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.9734/bjmmr/2017/34207\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British journal of medicine and medical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/bjmmr/2017/34207","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Potential Neuro-therapeutic Effect of Flaxseed Oil on the Striatum of Rotenone Mice Model of Parkinson’ Diseases
Aim: This study investigated the potential neuro-therapeutic effect of Flaxseed oil on the striatum of Rotenone mice model of Parkinson’ diseases’ Study Design: Fifty-six adult male and female mice ( Mus musculus) weighing between 23.9-26.3 grams were used for this study. The mice were randomly placed into four groups of fourteen mice each made up of equal number of male and female: A (Control; mice pellets), B (Rotenone 3 mg/kg, IP), C (Rotenone + Flaxseed oil 0.3 ml orally), and D (0.3 ml Flaxseed + Rotenone). Methodology: The brain were excised, weighed and appropriate sections taken and processed histology and stained with H&E and Nissl stains and immuno-cytochemically with GFAP. Results: The results showed significant (P<0.05) reduction in the neuronal cell count, body and relative brain to body weight, which were increased by flaxseed oil treatments. Rotenone induced neural and striatal bundle degeneration which were ameliorated by flaxseed oil treatment. Conclusion: In conclusion, the reduction in weight and neuronal derangements associated with rotenone induced Parkinson’s disease in this study were reduced or alleviated as a consequence of the treatment with flaxseed oil, and hence flaxseed oil could be considered as a potential therapeutic candidate in the management of Parkinson's disease.